HIGHLIGHTS
- who: Emanuela Grassilli from the Institute for Endocrinology and Salvatore (CNR), Italy Medical University of Warsaw, Poland have published the paper: BTK, the new kid on the (oncology) block?, in the Journal: (JOURNAL)
- what: In the last decade, it has become evident that not only BTK is central to several signaling pathways, relaying many receptors with diverse downstream effectors in bone marrowderived cells but that - expressed in different isoforms - is also pivotal for many tumor cells (Figure 3).
SUMMARY
In fact, its activity was found necessary for relaying the signals triggered . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.